Galapagos is working with another Private Briefing winner – AbbVie Inc. (NYSE: ABBV) – on cystic fibrosis (CF) drugs. The two companies are pursuing opportunities in one of the hottest slices of biotech right now – multi-drug therapies.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.